Elysium Health, Inc. v. ChromaDex, Inc.

CourtCourt of Appeals for the Second Circuit
DecidedOctober 26, 2023
Docket22-1059
StatusUnpublished

This text of Elysium Health, Inc. v. ChromaDex, Inc. (Elysium Health, Inc. v. ChromaDex, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Elysium Health, Inc. v. ChromaDex, Inc., (2d Cir. 2023).

Opinion

22-1059-cv Elysium Health, Inc. v. ChromaDex, Inc.

UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT SUMMARY ORDER RULINGS BY SUMMARY ORDER DO NOT HAVE PRECEDENTIAL EFFECT. CITATION TO A SUMMARY ORDER FILED ON OR AFTER JANUARY 1, 2007, IS PERMITTED AND IS GOVERNED BY FEDERAL RULE OF APPELLATE PROCEDURE 32.1 AND THIS COURT’S LOCAL RULE 32.1.1. WHEN CITING A SUMMARY ORDER IN A DOCUMENT FILED WITH THIS COURT, A PARTY MUST CITE EITHER THE FEDERAL APPENDIX OR AN ELECTRONIC DATABASE (WITH THE NOTATION “SUMMARY ORDER”). A PARTY CITING A SUMMARY ORDER MUST SERVE A COPY OF IT ON ANY PARTY NOT REPRESENTED BY COUNSEL.

At a stated term of the United States Court of Appeals for the Second Circuit, held at the Thurgood Marshall United States Courthouse, 40 Foley Square, in the City of New York, on the 26th day of October, two thousand twenty-three. Present: PIERRE N. LEVAL, BARRINGTON D. PARKER, WILLIAM J. NARDINI, Circuit Judges.

_____________________________________ ELYSIUM HEALTH, INC., Plaintiff-Counter Claimant-Appellant-Cross-Appellee, v. 22-1059-cv (Lead) 22-1153-cv (XAP) CHROMADEX, INC., Defendant-Counter Defendant-Appellee-Cross-Appellant. _____________________________________

For Appellant-Cross-Appellee: CRAIG B. WHITNEY (Tiffany R. Caterina, Los Angeles, CA, on the brief), Frankfurt Kurnit Klein & Selz PC, New York, NY

For Appellee-Cross-Appellant: JOEDAT H. TUFFAHA (Kate Elizabeth Cassidy, on the brief), LTL Attorneys LLP, Los Angeles, CA

1 Appeal from a judgment of the United States District Court for the Southern District of

New York (Lewis J. Liman, District Judge).

UPON DUE CONSIDERATION, IT IS HEREBY ORDERED, ADJUDGED, AND

DECREED that the judgment of the district court is AFFIRMED.

Appellant-Cross-Appellee Elysium Health, Inc. (“Elysium”) appeals from a judgment of

the United States District Court for the Southern District of New York (Lewis J. Liman, District

Judge), entered on April 28, 2022, enforcing a settlement agreement between Elysium and

Appellee-Cross-Appellant ChromaDex, Inc. (“ChromaDex”). The disputed settlement arose from

settlement discussions between Elysium’s and ChromaDex’s in-house legal counsels, Thomas

Wilhelm and William Carter, respectively. In a call on February 2, 2022 (the “February 2 Call”),

the parties discussed a possible settlement agreement, and Carter said that if Elysium agreed to the

terms proposed by Carter, the parties would have a deal. In an email on February 3, 2022 (the

“February 3 Email”), Wilhelm wrote, “we can accept the additional terms you proposed

yesterday,” listed the terms of the agreement, and then stated, “I understand that now that we have

an agreement you will begin work on documentation.” App’x at 1301. The agreement discussed

on the call and written out in the email would resolve the outstanding litigation between them

before the district court as well as another dispute before a federal court in California, which

resolution would include a $2.5 million payment in two installments from Elysium to ChromaDex.

Just a couple hours after Elysium’s February 3 Email, agreeing to the terms proposed by

ChromaDex, the district court, unaware of the settlement, issued its decision on the parties’

summary judgment and Daubert motions. The district court’s decision was favorable to Elysium,

dismissing ChromaDex’s complaint in full and allowing Elysium’s counterclaims to survive in

part. After seeing the district court’s summary judgment decision, Elysium told ChromaDex that

2 in fact no settlement had been reached yet. ChromaDex moved for the district court to enforce the

settlement agreement, which the district court granted. This appeal followed. We assume the

parties’ familiarity with the case.

In an appeal from a district court’s order enforcing a settlement agreement, “[w]e review

the district court’s findings of law under a de novo standard, and its factual conclusions under a

clearly erroneous standard of review.” Ciaramella v. Reader’s Digest Ass’n, Inc., 131 F.3d 320,

322 (2d Cir. 1997). 1 “A finding of fact is clearly erroneous only if the appellate court is left with

the definite and firm conviction that a mistake has been committed.” United States v. Rizzo, 349

F.3d 94, 98 (2d Cir. 2003). “If the district court’s account of the evidence is plausible in light of

the record viewed in its entirety, the court of appeals may not reverse it even though convinced

that had it been sitting as the trier of fact, it would have weighed the evidence differently.”

Anderson v. City of Bessemer City, 470 U.S. 564, 573–74 (1985).

I. Mutual Assent

Elysium first argues that the district court clearly erred in finding that there was mutual

assent to form a binding settlement agreement. “It is a basic tenet of contract law that, in order to

be binding, a contract requires a meeting of the minds and a manifestation of mutual assent. . . . As

a general matter, courts look to the basic elements of the offer and acceptance to determine if there

was an objective meeting of the minds sufficient to create a binding and enforceable contract.”

Fisher v. Aetna Life Ins. Co., 32 F.4th 124, 136 (2d Cir. 2022). 2 Elysium takes issue with the

1 Unless otherwise indicated, case quotations omit all internal quotation marks, footnotes, and citations and adopt all alterations. We apply New York state law to this case because the parties’ briefs both assume New York state law 2

governs and such, “implied consent is . . . sufficient to establish the applicable choice of law.” Trikona Advisers Ltd. v. Chugh, 846 F.3d 22, 31 (2d Cir. 2017) (quoting Arch Ins. Co. v. Precision Stone, Inc., 584 F.3d 33, 39 (2d Cir. 2009)).

3 district court’s factual finding that it was “without contradiction” that Carter told Wilhelm on the

February 2 Call that “if Elysium agreed to the terms he laid out then the parties would have a deal.”

In re Elysium Health-ChromaDex Litig., No. 17-cv-7394, 2022 WL 1156181, at *5 (S.D.N.Y. Apr.

19, 2022). According to Elysium, Wilhelm’s declaration regarding what occurred on the February

2 Call does, in fact, contradict Carter’s declaration because it states that he and Carter “did not

discuss all of the terms from the parties’ prior communications” on the call, but rather only

“additional settlement terms” regarding the $2.5 million payment from Elysium to ChromaDex.

App’x at 1305. Carter’s declaration states that all of the terms of the settlement were “conveyed”

on the call. Id. at 1292.

The district court did not clearly err in finding that there was no dispute that ChromaDex

had conveyed all of the material terms of the settlement offer. It is possible for Carter to have

“conveyed” the material terms on the February 2 Call, id., while having only “discuss[ed]” the

additional guarantees regarding the $2.5 million payment, id. at 1305. In other words, if Carter

and Wilhelm already understood what were the other terms of the settlement proposal, then Carter

could convey the full offer by discussing the additional terms and only alluding to the other

material terms or not even mentioning them on February 2, if it had already been clearly

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Elysium Health, Inc. v. ChromaDex, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/elysium-health-inc-v-chromadex-inc-ca2-2023.